Does GLOFITAMAB-GXBM Cause Off label use? 68 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 68 reports of Off label use have been filed in association with GLOFITAMAB-GXBM. This represents 13.7% of all adverse event reports for GLOFITAMAB-GXBM.
68
Reports of Off label use with GLOFITAMAB-GXBM
13.7%
of all GLOFITAMAB-GXBM reports
9
Deaths
17
Hospitalizations
How Dangerous Is Off label use From GLOFITAMAB-GXBM?
Of the 68 reports, 9 (13.2%) resulted in death, 17 (25.0%) required hospitalization, and 6 (8.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB-GXBM. However, 68 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB-GXBM Cause?
Cytokine release syndrome (107)
Disease progression (68)
Death (67)
Pyrexia (45)
No adverse event (28)
Immune effector cell-associated neurotoxicity syndrome (25)
Infection (20)
Pneumonia (14)
Condition aggravated (12)
Covid-19 (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GLOFITAMAB-GXBM Alternatives Have Lower Off label use Risk?
GLOFITAMAB-GXBM vs GLUCAGON
GLOFITAMAB-GXBM vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB-GXBM vs GLUCARPIDASE
GLOFITAMAB-GXBM vs GLUCOPHAGE
GLOFITAMAB-GXBM vs GLUCOSAMINE